Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | CPA1 | P15085 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14930533 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL7717660 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL22305848 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TDP1 | |
| SCHEMBL27796756 | 0.78 | ALDH1A1 (0.39) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL161143 | 0.78 | — | — | |
| SCHEMBL23483772 | 0.77 | — | — | |
| SCHEMBL9803026 | 0.77 | SLC7A5 (0.46) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL16267760 | 0.76 | — | — | |
| SCHEMBL203810 | 0.76 | — | — | |
| SCHEMBL25407138 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130161-A2 | NOVEL CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF | BIONECURE THERAPEUTICS INC (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2023-09-21 | — | — | US | disclosed |
| US-11564388-B2 | Supercooling methods for preservation of biological samples | X-THERMA, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-4013440-A1 | THERAPEUTIC PEPTIDES | Cohbar Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| EP-3997231-A1 | METHODS FOR MAKING RECOMBINANT PROTEIN | Monash University (AU) | 2022-05-18 | — | — | EP | disclosed |
| US-20210061755-A1 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) | 2021-03-04 | — | — | US | disclosed |
| WO-2021030792-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. (US) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021030752-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. (US) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021030469-A1 | THERAPEUTIC MITOCHONDRIAL PEPTIDES | COHBAR, INC. (US) | 2021-02-18 | — | — | WO | disclosed |
| WO-2013114363-A2 | ANTIMICROBIAL AGENTS | YEDA RESEARCH AND DEVELOPMENT CO.LTD. (IL) | 2013-08-08 | — | — | WO | disclosed |
| EP-2600885-A2 | METHODS OF TREATING AUTOIMMUNE DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) AND NEURODEGENERATIVE DISEASES | Ramot at Tel Aviv University, Ltd. (IL) | 2013-06-12 | — | — | EP | disclosed |
| WO-2013059885-A2 | POLYPEPTIDE CONSTRUCTS AND USES THEREOF | CEPHALON AUSTRALIA PTY LTD (AU) | 2013-05-02 | — | — | WO | disclosed |
| WO-2013030840-A2 | ADHESIVE BIOPOLYMERS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-03-07 | — | — | WO | disclosed |
| EP-2478009-A1 | PEPTIDES FOR THE TREATMENT OF OXIDATIVE STRESS RELATED DISORDERS | Ramot at Tel-Aviv University Ltd. (IL) | 2012-07-25 | — | — | EP | disclosed |
| WO-2012017439-A2 | METHODS OF TREATING AUTOIMMUNE DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) AND NEURODEGENERATIVE DISEASES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2012-02-09 | — | — | WO | disclosed |
| WO-2011033506-A9 | ISOLATED PON1 POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF IN TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2011-05-05 | — | — | WO | disclosed |
| WO-2011033511-A1 | PEPTIDES FOR THE TREATMENT OF OXIDATIVE STRESS RELATED DISORDERS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-03-24 | — | — | WO | disclosed |
| EP-1756272-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS OF PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH AMYLOID FIBRIL FORMATION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005066337-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS OF PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH AMYLOID FIBRIL FORMATION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2005-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11564388-B2 | Supercooling methods for preservation of biological samples | PPIG, AQP3, PYGB | ALDH1A1 4840/4885LMNA 157/4885MAPT 1057/4885 |
| US-20210061755-A1 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | PDCD1, CD274, PDCD1LG2 | ALDH1A1 69/4885LMNA 2222/4885MAPT 2465/4885 |
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | PPIG, AQP3, AQP1 | ALDH1A1 4823/4885LMNA 195/4885MAPT 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.